Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 55

    1.

    Asymptomatic Pancreatic Cyst Neoplasms: Maximizing Survival and Quality of Life Using Markov-based Clinical Nomograms.

    Weinberg BM, Spiegel BM, S Tomlinson J, Farrell JJ.

    Gastroenterology. 2009 Oct 7. [Epub ahead of print]PMID: 19818780 [PubMed - as supplied by publisher]Related articles

    2.

    Endoscopy for acute upper GI tract hemorrhage: sooner is better.

    Spiegel BM.

    Gastrointest Endosc. 2009 Aug;70(2):236-9. No abstract available. PMID: 19631802 [PubMed - indexed for MEDLINE]Related articles

    3.

    Fewer polyps detected by colonoscopy as the day progresses at a Veteran's Administration teaching hospital.

    Chan MY, Cohen H, Spiegel BM.

    Clin Gastroenterol Hepatol. 2009 Nov;7(11):1217-23; quiz 1143. Epub 2009 Jul 22.PMID: 19631284 [PubMed - in process]Related articles

    4.

    The burden of IBS: looking at metrics.

    Spiegel BM.

    Curr Gastroenterol Rep. 2009 Aug;11(4):265-9. Review.PMID: 19615301 [PubMed - indexed for MEDLINE]Related articles

    5.

    Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis.

    Ford AC, Spiegel BM, Talley NJ, Moayyedi P.

    Clin Gastroenterol Hepatol. 2009 Aug 12. [Epub ahead of print]PMID: 19602448 [PubMed - as supplied by publisher]Related articles

    6.

    The relationship between laboratory-based outcome measures and mortality in end-stage renal disease: a systematic review.

    Desai AA, Nissenson A, Chertow GM, Farid M, Singh I, Van Oijen MG, Esrailian E, Solomon MD, Spiegel BM.

    Hemodial Int. 2009 Jul;13(3):347-59. Epub 2009 Jul 3.PMID: 19583604 [PubMed - in process]Related articles

    7.

    An evidence-based position statement on the management of irritable bowel syndrome.

    American College of Gastroenterology Task Force on Irritable Bowel Syndrome, Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, Talley NJ, Quigley EM.

    Am J Gastroenterol. 2009 Jan;104 Suppl 1:S1-35. Review. No abstract available. PMID: 19521341 [PubMed - indexed for MEDLINE]Related articles

    8.

    Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis.

    Ford AC, Chey WD, Talley NJ, Malhotra A, Spiegel BM, Moayyedi P.

    Arch Intern Med. 2009 Apr 13;169(7):651-8. Review.PMID: 19364994 [PubMed - indexed for MEDLINE]Related articles

    9.

    Is there "cherry picking" in the ESRD Program? Perceptions from a Dialysis Provider Survey.

    Desai AA, Bolus R, Nissenson A, Chertow GM, Bolus S, Solomon MD, Khawar OS, Talley J, Spiegel BM.

    Clin J Am Soc Nephrol. 2009 Apr;4(4):772-7. Epub 2009 Apr 1.PMID: 19339407 [PubMed - indexed for MEDLINE]Related articles

    10.

    Health-related quality of life predicts mortality in patients with advanced chronic liver disease.

    Kanwal F, Gralnek IM, Hays RD, Zeringue A, Durazo F, Han SB, Saab S, Bolus R, Spiegel BM.

    Clin Gastroenterol Hepatol. 2009 Jul;7(7):793-9. Epub 2009 Mar 21.PMID: 19306949 [PubMed - indexed for MEDLINE]Related articles

    11.

    Adherence to best practice guidelines in dyspepsia: a survey comparing dyspepsia experts, community gastroenterologists and primary-care providers.

    Spiegel BM, Farid M, van Oijen MG, Laine L, Howden CW, Esrailian E.

    Aliment Pharmacol Ther. 2009 Apr 15;29(8):871-81. Epub 2009 Jan 15.PMID: 19183152 [PubMed - indexed for MEDLINE]Related articles

    12.

    Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors?

    Spiegel BM, Chey WD, Chang L.

    Am J Gastroenterol. 2008 Dec;103(12):2972-6.PMID: 19086951 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis.

    Ford AC, Talley NJ, Spiegel BM, Foxx-Orenstein AE, Schiller L, Quigley EM, Moayyedi P.

    BMJ. 2008 Nov 13;337:a2313. doi: 10.1136/bmj.a2313. Review. Erratum in: BMJ.2009;338:b1881. PMID: 19008265 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists.

    Spiegel BM, Ho W, Esrailian E, Targan S, Higgins PD, Siegel CA, Dubinsky M, Melmed GY.

    Clin Gastroenterol Hepatol. 2009 Feb;7(2):168-74, 174.e1. Epub 2008 Sep 4.PMID: 18952199 [PubMed - indexed for MEDLINE]Related articles

    15.

    Biomarkers and health-related quality of life in end-stage renal disease: a systematic review.

    Spiegel BM, Melmed G, Robbins S, Esrailian E.

    Clin J Am Soc Nephrol. 2008 Nov;3(6):1759-68. Epub 2008 Oct 1. Review.PMID: 18832106 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Evaluating the process of care in nonvariceal upper gastrointestinal haemorrhage: a survey of expert vs. non-expert gastroenterologists.

    Esrailian E, Gralnek IM, Jensen D, Laine L, Dulai GS, Eisen G, Spiegel BM.

    Aliment Pharmacol Ther. 2008 Nov 15;28(10):1199-208. Epub 2008 Aug 24.PMID: 18729846 [PubMed - indexed for MEDLINE]Related articles

    17.

    Prospective validation of the short form liver disease quality of life instrument.

    Kanwal F, Spiegel BM, Hays RD, Durazo F, Han SB, Saab S, Bolus R, Kim SJ, Gralnek IM.

    Aliment Pharmacol Ther. 2008 Nov 1;28(9):1088-101. Epub 2008 Jul 30.PMID: 18671776 [PubMed - indexed for MEDLINE]Related articles

    18.

    Identifying best practices in dialysis care: results of cognitive interviews and a national survey of dialysis providers.

    Desai AA, Bolus R, Nissenson A, Bolus S, Solomon MD, Khawar O, Gitlin M, Talley J, Spiegel BM.

    Clin J Am Soc Nephrol. 2008 Jul;3(4):1066-76. Epub 2008 Apr 16.PMID: 18417745 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Comparison of health-related quality of life between populations.

    Slavenburg S, van Oijen MG, Spiegel BM.

    Liver Int. 2008 Feb;28(2):285-6; author reply 286-7. No abstract available. PMID: 18251985 [PubMed - indexed for MEDLINE]Related articles

    20.

    Predictors of treatment in patients with chronic hepatitis C infection - role of patient versus nonpatient factors.

    Kanwal F, Hoang T, Spiegel BM, Eisen S, Dominitz JA, Gifford A, Goetz M, Asch SM.

    Hepatology. 2007 Dec;46(6):1741-9.PMID: 18046707 [PubMed - indexed for MEDLINE]Related articles

    21.

    Functional GI disorders: from animal models to drug development.

    Mayer EA, Bradesi S, Chang L, Spiegel BM, Bueller JA, Naliboff BD.

    Gut. 2008 Mar;57(3):384-404. Epub 2007 Oct 26. Review.PMID: 17965064 [PubMed - indexed for MEDLINE]Related articles

    22.

    The budget impact of endoscopic screening for esophageal varices in cirrhosis.

    Spiegel BM, Esrailian E, Eisen G.

    Gastrointest Endosc. 2007 Oct;66(4):679-92.PMID: 17905009 [PubMed - indexed for MEDLINE]Related articles

    23.

    The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy - a decision analysis.

    Huang E, Esrailian E, Spiegel BM.

    Aliment Pharmacol Ther. 2007 Oct 15;26(8):1147-61.PMID: 17894657 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Differences in the management of Crohn's disease among experts and community providers, based on a national survey of sample case vignettes.

    Esrailian E, Spiegel BM, Targownik LE, Dubinsky MC, Targan SR, Gralnek IM.

    Aliment Pharmacol Ther. 2007 Oct 1;26(7):1005-18.PMID: 17877507 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Clinical impact of adjuvant chemotherapy in glioblastoma multiforme : a meta-analysis.

    Spiegel BM, Esrailian E, Laine L, Chamberlain MC.

    CNS Drugs. 2007;21(9):775-87. Review.PMID: 17696576 [PubMed - indexed for MEDLINE]Related articles

    26.

    Development and validation of a disease-targeted quality of life instrument in chronic hepatitis B: the hepatitis B quality of life instrument, version 1.0.

    Spiegel BM, Bolus R, Han S, Tong M, Esrailian E, Talley J, Tran T, Smith J, Karsan HA, Durazo F, Bacon B, Martin P, Younossi Z, Hwa-Ong S, Kanwal F.

    Hepatology. 2007 Jul;46(1):113-21.PMID: 17596882 [PubMed - indexed for MEDLINE]Related articles

    27.

    Do physicians follow evidence-based guidelines in the diagnostic work-up of IBS?

    Spiegel BM.

    Nat Clin Pract Gastroenterol Hepatol. 2007 Jun;4(6):296-7. No abstract available. PMID: 17541444 [PubMed - indexed for MEDLINE]Related articles

    28.

    The cost-effectiveness of colonic stenting as a bridge to curative surgery in patients with acute left-sided malignant colonic obstruction: a Canadian perspective.

    Singh H, Latosinsky S, Spiegel BM, Targownik LE.

    Can J Gastroenterol. 2006 Dec;20(12):779-85.PMID: 17171197 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials.

    Gralnek IM, Dulai GS, Fennerty MB, Spiegel BM.

    Clin Gastroenterol Hepatol. 2006 Dec;4(12):1452-8.PMID: 17162239 [PubMed - indexed for MEDLINE]Related articles

    30.

    Treatment alternatives for hepatitis B cirrhosis: a cost-effectiveness analysis.

    Kanwal F, Farid M, Martin P, Chen G, Gralnek IM, Dulai GS, Spiegel BM.

    Am J Gastroenterol. 2006 Sep;101(9):2076-89.PMID: 16968510 [PubMed - indexed for MEDLINE]Related articles

    31.

    The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage.

    Spiegel BM, Dulai GS, Lim BS, Mann N, Kanwal F, Gralnek IM.

    Clin Gastroenterol Hepatol. 2006 Aug;4(8):988-997. Epub 2006 Jul 17.PMID: 16844422 [PubMed - indexed for MEDLINE]Related articles

    32.

    Comparing rates of dyspepsia with Coxibs vs NSAID+PPI: a meta-analysis.

    Spiegel BM, Farid M, Dulai GS, Gralnek IM, Kanwal F.

    Am J Med. 2006 May;119(5):448.e27-36.PMID: 16651060 [PubMed - indexed for MEDLINE]Related articles

    33.

    Is a negative colonoscopy associated with reassurance or improved health-related quality of life in irritable bowel syndrome?

    Spiegel BM, Gralnek IM, Bolus R, Chang L, Dulai GS, Naliboff B, Mayer EA.

    Gastrointest Endosc. 2005 Dec;62(6):892-9.PMID: 16301033 [PubMed - indexed for MEDLINE]Related articles

    34.

    Erythropoietic growth factors for treatment-induced anemia in hepatitis C: a cost-effectiveness analysis.

    Spiegel BM, Chen K, Chiou CF, Robbins S, Younossi ZM.

    Clin Gastroenterol Hepatol. 2005 Oct;3(10):1034-42.PMID: 16234051 [PubMed - indexed for MEDLINE]Related articles

    35.

    The impact of somatization on the use of gastrointestinal health-care resources in patients with irritable bowel syndrome.

    Spiegel BM, Kanwal F, Naliboff B, Mayer E.

    Am J Gastroenterol. 2005 Oct;100(10):2262-73.PMID: 16181379 [PubMed - indexed for MEDLINE]Related articles

    36.

    Impact of chronic viral hepatitis on health-related quality of life in HIV: results from a nationally representative sample.

    Kanwal F, Gralnek IM, Hays RD, Dulai GS, Spiegel BM, Bozzette S, Asch S.

    Am J Gastroenterol. 2005 Sep;100(9):1984-94.PMID: 16128943 [PubMed - indexed for MEDLINE]Related articles

    37.

    Traditional Chinese medicine based subgrouping of irritable bowel syndrome patients.

    Tan S, Tillisch K, Bolus SR, Olivas TI, Spiegel BM, Naliboff B, Chang L, Mayer EA.

    Am J Chin Med. 2005;33(3):365-79.PMID: 16047555 [PubMed - indexed for MEDLINE]Related articles

    38.

    Budget impact of tegaserod on a managed care organization formulary.

    Bloom MA, Barghout V, Kahler KH, Bentkover J, Kurth H, Gralnek IM, Spiegel BM.

    Am J Manag Care. 2005 Apr;11(1 Suppl):S27-34.PMID: 15926761 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis.

    Kanwal F, Gralnek IM, Martin P, Dulai GS, Farid M, Spiegel BM.

    Ann Intern Med. 2005 May 17;142(10):821-31.PMID: 15897532 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups.

    Spiegel BM, Chiou CF, Ofman JJ.

    Arthritis Rheum. 2005 Apr 15;53(2):185-97. Review.PMID: 15818647 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment.

    Spiegel BM, Younossi ZM, Hays RD, Revicki D, Robbins S, Kanwal F.

    Hepatology. 2005 Apr;41(4):790-800. Review.PMID: 15791608 [PubMed - indexed for MEDLINE]Related articles

    42.

    Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.

    Dulai GS, Shekelle PG, Jensen DM, Spiegel BM, Chen J, Oh D, Kahn KL.

    Am J Gastroenterol. 2005 Apr;100(4):775-83.PMID: 15784018 [PubMed - indexed for MEDLINE]Related articles

    43.

    Combination endoscopic band ligation and sclerotherapy compared with endoscopic band ligation alone for the secondary prophylaxis of esophageal variceal hemorrhage: a meta-analysis.

    Karsan HA, Morton SC, Shekelle PG, Spiegel BM, Suttorp MJ, Edelstein MA, Gralnek IM.

    Dig Dis Sci. 2005 Feb;50(2):399-406.PMID: 15745108 [PubMed - indexed for MEDLINE]Related articles

    44.

    A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras.

    Kanwal F, Dulai GS, Spiegel BM, Yee HF, Gralnek IM.

    Aliment Pharmacol Ther. 2005 Jan 15;21(2):169-77.PMID: 15679767 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Colonic stent vs. emergency surgery for management of acute left-sided malignant colonic obstruction: a decision analysis.

    Targownik LE, Spiegel BM, Sack J, Hines OJ, Dulai GS, Gralnek IM, Farrell JJ.

    Gastrointest Endosc. 2004 Dec;60(6):865-74.PMID: 15604999 [PubMed - indexed for MEDLINE]Related articles

    46.

    Clinical determinants of health-related quality of life in patients with irritable bowel syndrome.

    Spiegel BM, Gralnek IM, Bolus R, Chang L, Dulai GS, Mayer EA, Naliboff B.

    Arch Intern Med. 2004 Sep 13;164(16):1773-80.PMID: 15364671 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    The quality of published health economic analyses in digestive diseases: a systematic review and quantitative appraisal.

    Spiegel BM, Targownik LE, Kanwal F, Derosa V, Dulai GS, Gralnek IM, Chiou CF.

    Gastroenterology. 2004 Aug;127(2):403-11. Review.PMID: 15300571 [PubMed - indexed for MEDLINE]Related articles

    48.

    The cost-effectiveness of hepatic venous pressure gradient monitoring in the prevention of recurrent variceal hemorrhage.

    Targownik LE, Spiegel BM, Dulai GS, Karsan HA, Gralnek IM.

    Am J Gastroenterol. 2004 Jul;99(7):1306-15.PMID: 15233670 [PubMed - indexed for MEDLINE]Related articles

    49.

    Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis.

    Spiegel BM, DeRosa VP, Gralnek IM, Wang V, Dulai GS.

    Gastroenterology. 2004 Jun;126(7):1721-32.PMID: 15188167 [PubMed - indexed for MEDLINE]Related articles

    50.

    Management of acute nonvariceal upper gastrointestinal hemorrhage: comparison of an American and a Canadian medical centre.

    Targownik LE, Gralnek IM, Dulai GS, Spiegel BM, Oei T, Bernstein CN.

    Can J Gastroenterol. 2003 Aug;17(8):489-95.PMID: 12945010 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...